ASX:HSO - Healthscope Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started A$2.46 +0.01 (+0.41 %) (As of 05/20/2019 04:00 PM ET)Previous CloseA$2.45Today's RangeA$2.46 - A$2.4752-Week RangeA$1.77 - A$2.50Volume9.14 million shsAverage Volume6.04 million shsMarket Capitalization$4.28 billionP/E Ratio17.32Dividend Yield2.87%BetaN/A ProfileChartDividendInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Healthscope Limited provides healthcare services in Australia and New Zealand. The company operates through Hospitals Australia and Pathology New Zealand segments. It operates 43 private hospitals, including 30 acute hospitals, 7 mental health hospitals, and 6 rehabilitation hospitals with approximately 5,000 inpatient beds. The company also provides human pathology services under the Labtests, Southern Community Laboratories, and Northland Pathology brands; and veterinary and analytical pathology services under the Gribbles brand. The company was formerly known as Healthscope Hospitals Holdings Pty. Ltd. and changed its name to Healthscope Limited in July 2014. Healthscope Limited was founded in 1985 and is headquartered in Melbourne, Australia. Receive HSO News and Ratings via Email Sign-up to receive the latest news and ratings for HSO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ASX Industry Hospitals Sub-IndustryN/A SectorMedical Current SymbolASX:HSO Previous Symbol CUSIPN/A CIKN/A Webwww.healthscope.com.au Phone+61-3-99267500Debt Debt-to-Equity Ratio52.04 Current Ratio0.46 Quick Ratio0.35Price-To-Earnings Trailing P/E Ratio17.32 Forward P/E Ratio20.50 P/E GrowthN/A Sales & Book Value Annual Sales$2.38 billion Price / Sales1.80 Cash FlowA$0.06 per share Price / Cash Flow39.68 Book ValueA$1.46 per share Price / Book1.69Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees17,100 Outstanding Shares1,741,159,936Market Cap$4.28 billion Next Earnings DateN/A OptionableNot Optionable Healthscope (ASX:HSO) Frequently Asked Questions What is Healthscope's stock symbol? Healthscope trades on the ASX under the ticker symbol "HSO." How often does Healthscope pay dividends? What is the dividend yield for Healthscope? Healthscope declared a Interim dividend on Friday, February 15th. Stockholders of record on Tuesday, March 26th will be given a dividend of 0.035 per share on Tuesday, March 26th. This represents a dividend yield of 1.42%. The ex-dividend date is Monday, March 4th. View Healthscope's Dividend History. Has Healthscope been receiving favorable news coverage? Media coverage about HSO stock has trended somewhat negative recently, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Healthscope earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. Who are some of Healthscope's key competitors? Some companies that are related to Healthscope include Ramsay Health Care Limited Fully Paid Ord. Shrs (RHC), Encompass Health (EHC), MEDNAX (MD), Select Medical (SEM), Magellan Health (MGLN), Primary Health Care (PRY), Medical Facilities (DR), Capitol Health (CAJ), Animalcare Group (ANCR), SunLink Health Systems (SSY), Spine Injury Solutions (SPIN) and THC Biomed Intl (THC). What other stocks do shareholders of Healthscope own? Based on aggregate information from My MarketBeat watchlists, some companies that other Healthscope investors own include E Tracs Ubs Blomberg Cmci Energy Etn (UBN), Primary Health Care (PRY) and Fortescue Metals Group (FMG). Who are Healthscope's key executives? Healthscope's management team includes the folowing people: Mr. Gordon Scott Ballantyne, MD, CEO & Director (Age 54)Mr. Michael Sammells, Chief Financial OfficerMr. Mark Briscoe, Gen. Mang. of OperationsMr. David Shirer, Gen. Mang. of Investor RelationsMs. Ingrid A. Player, Group Exec. of Legal, Governance & Sustainability, Gen. Counsel and Sec. (Age 46) What is Healthscope's stock price today? One share of HSO stock can currently be purchased for approximately A$2.46. How big of a company is Healthscope? Healthscope has a market capitalization of $4.28 billion and generates $2.38 billion in revenue each year. Healthscope employs 17,100 workers across the globe. What is Healthscope's official website? The official website for Healthscope is http://www.healthscope.com.au/. How can I contact Healthscope? Healthscope's mailing address is Level 1, 312 St. Kilda Road, MELBOURNE, VIC 3001, Australia. The company can be reached via phone at +61-3-99267500. MarketBeat Community Rating for Healthscope (ASX HSO)Community Ranking: 3.3 out of 5 ( )Outperform Votes: 65 (Vote Outperform)Underperform Votes: 34 (Vote Underperform)Total Votes: 99MarketBeat's community ratings are surveys of what our community members think about Healthscope and other stocks. Vote "Outperform" if you believe HSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HSO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: Retained Earnings Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.